The heart and the gut.
暂无分享,去创建一个
[1] Stephan von Haehling,et al. Inflammatory mediators in chronic heart failure: an overview , 2004, Heart.
[2] J. Danesh,et al. Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.
[3] P. Turnbaugh,et al. The core gut microbiome, energy balance and obesity , 2009, The Journal of physiology.
[4] D. Morel,et al. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. , 1986, Laboratory investigation; a journal of technical methods and pathology.
[5] Yaoyu E. Wang,et al. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[6] D. Gevers,et al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis , 2011, Inflammatory bowel diseases.
[7] S. Anker,et al. The gut and intestinal bacteria in chronic heart failure. , 2009, Current drug metabolism.
[8] R. Sartor. Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis. , 2010, Gastroenterology.
[9] Soo-Ho Choi,et al. Low Doses of Lipopolysaccharide and Minimally Oxidized Low-Density Lipoprotein Cooperatively Activate Macrophages via Nuclear Factor &kgr;B and Activator Protein-1: Possible Mechanism for Acceleration of Atherosclerosis by Subclinical Endotoxemia , 2010, Circulation research.
[10] M. Hirata,et al. Statin regulation of CYP3A4 and CYP3A5 expression. , 2009, Pharmacogenomics.
[11] D. Graham,et al. Detection of Chlamydiae pneumoniae but Not Helicobacter pylori DNA in Atherosclerosis Plaques , 2003, Digestive Diseases and Sciences.
[12] S. Anker,et al. Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. , 2002, The American journal of cardiology.
[13] Kazuto Nakamura,et al. Adiponectin Attenuates Lipopolysaccharide-Induced Acute Lung Injury through Suppression of Endothelial Cell Activation , 2012, The Journal of Immunology.
[14] M. Nieminen,et al. SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.
[15] Sharon I. Greenblum,et al. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease , 2011, Proceedings of the National Academy of Sciences.
[16] E. Verrier,et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. , 2004, The Journal of thoracic and cardiovascular surgery.
[17] Christopher M O'Connor,et al. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. , 2003, JAMA.
[18] D. Strachan,et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.
[19] Josef Niebauer,et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study , 1999, The Lancet.
[20] G. Novo,et al. Atherosclerosis, inflammation and Chlamydia pneumoniae. , 2009, World journal of cardiology.
[21] A. Camm,et al. Effect of Treatment for Chlamydia pneumoniae and Helicobacter pylori on Markers of Inflammation and Cardiac Events in Patients With Acute Coronary Syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA) , 2002, Circulation.
[22] S. Anker,et al. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure , 2000, Circulation.
[23] Haifeng Lu,et al. Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.
[24] F. Hassan,et al. Lipopolysaccharide and interferon‐γ enhance Fas‐mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression , 2007, Clinical and experimental immunology.
[25] R. Saggini,et al. Botulinum Toxin in Cerebral Child Palsy , 2009, International journal of immunopathology and pharmacology.
[26] H. Robenek,et al. Endocytosis of oxidized LDL and reversibility of migration inhibition in macrophage-derived foam cells in vitro. A mechanism for atherosclerosis regression? , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[27] P. Tothill,et al. Acetaminophen absorption and metabolism in celiac disease and Crohn's disease , 1981, Clinical pharmacology and therapeutics.
[28] K. Walley,et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. , 2006, Cardiovascular research.
[29] H. Niwa,et al. Alteration of histamine, serotonin and primary prostaglandin in case of diarrhea induced by endotoxin and gastrointestinal absorption of drug. , 1985, Journal of pharmacobio-dynamics.
[30] D. Schwartz,et al. Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.
[31] Haichang Wang,et al. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages. , 2010, Atherosclerosis.
[32] Dan Turner,et al. Alterations in the gut microbiome of children with severe ulcerative colitis , 2012, Inflammatory bowel diseases.
[33] W. Coyle,et al. The microbiome and obesity: Is obesity linked to our gut flora? , 2009, Current gastroenterology reports.
[34] K. Mccafferty,et al. Intestinal Microbiota Determine Severity of Myocardial Infarction in Rats , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] I-Min A. Chen,et al. IMG/M-HMP: A Metagenome Comparative Analysis System for the Human Microbiome Project , 2012, PloS one.
[36] P. Poole‐Wilson,et al. Cellular endotoxin desensitization in patients with severe chronic heart failure , 2005, European journal of heart failure.
[37] L. Badimón,et al. Lipopolysaccharide downregulates CD91/low-density lipoprotein receptor-related protein 1 expression through SREBP-1 overexpression in human macrophages. , 2013, Atherosclerosis.
[38] M. Cernadas. It takes a microbiome: commensals, immune regulation, and allergy. , 2011, American journal of respiratory and critical care medicine.
[39] V. Valtonen,et al. Infection as a risk factor for infarction and atherosclerosis. , 1991, Annals of medicine.
[40] J. Flier,et al. Gut Check: Testing a Role for the Intestinal Microbiome in Human Obesity , 2009, Science Translational Medicine.
[41] J E Parrillo,et al. Myocardial dysfunction in septic shock: Part I. Clinical manifestation of cardiovascular dysfunction. , 2001, Journal of cardiothoracic and vascular anesthesia.
[42] Guansong Wang,et al. Protection from lipopolysaccharide-induced pulmonary microvascular endothelial cell injury by activation of hedgehog signaling pathway , 2011, Molecular Biology Reports.
[43] C. Lang,et al. Decreased intestinal CYP3A in celiac disease: Reversal after successful gluten‐free diet: A potential source of interindividual variability in first‐pass drug metabolism , 1996, Clinical pharmacology and therapeutics.
[44] D. Kelly,et al. Toll-like Receptor-mediated Inflammatory Signaling Reprograms Cardiac Energy Metabolism by Repressing Peroxisome Proliferator-activated Receptor ␥ Coactivator-1 Signaling Clinical Perspective on P 482 Methods Animal Experiments and Generation Results Lps Stimulation Suppresses Cardiac Mitochondrial , 2022 .
[45] A. Dubin,et al. Gastric intramucosal pH as a therapeutic index of tissue oxygenation in critically ill patients , 1992, The Lancet.
[46] G. Wilkinson. Cytochrome P4503A (CYP3A) metabolism: Prediction ofIn Vivo activity in humans , 1996, Journal of Pharmacokinetics and Biopharmaceutics.
[47] J. Lovegrove,et al. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population , 2013, International Journal of Obesity.
[48] S. Kiechl,et al. Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study. , 1999, Journal of the American College of Cardiology.
[49] R. Neubig,et al. Phagocyte-derived catecholamines enhance acute inflammatory injury , 2007, Nature.
[50] N. Khardori. Exposure to Environmental Microorganisms and Childhood Asthma , 2011 .
[51] Katherine H. Huang,et al. Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.
[52] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[53] D. Hommes,et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Published, JLR Papers in Press, September 22, 2007. , 2007, Journal of Lipid Research.
[54] D. Acuña-Castroviejo,et al. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide , 2011, Journal of pineal research.
[55] R. Serov,et al. Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure. , 2008, International Journal of Cardiology.
[56] R. Terkeltaub,et al. Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[57] E. Porat,et al. Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia. , 2010, Journal of molecular and cellular cardiology.
[58] J. Neu,et al. The developing intestinal microbiome and its relationship to health and disease in the neonate , 2011, Journal of Perinatology.
[59] H. Ogawa,et al. Potential association of Helicobacter cinaedi with atrial arrhythmias and atherosclerosis , 2012, Microbiology and immunology.
[60] G. Schiavoni,et al. Chlamydia Pneumoniae and Atherosclerosis: Current State and Future Prospectives , 2009, International journal of immunopathology and pharmacology.
[61] P. Poole‐Wilson,et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. , 1997, The American journal of cardiology.
[62] M. Farkouh,et al. Are patients with inflammatory bowel disease at increased risk of coronary artery disease? , 2012, The American journal of medicine.
[63] P. Poole‐Wilson,et al. Altered intestinal function in patients with chronic heart failure. , 2007, Journal of the American College of Cardiology.
[64] Arthur Kaser,et al. Gut microbiome, obesity, and metabolic dysfunction. , 2011, The Journal of clinical investigation.
[65] E. Porat,et al. Toll-like receptor 4 stimulation initiates an inflammatory response that decreases cardiomyocyte contractility. , 2011, Antioxidants & redox signaling.
[66] L. Campbell,et al. Chlamydia pneumoniae — an infectious risk factor for atherosclerosis? , 2004, Nature Reviews Microbiology.
[67] Qingbo Xu,et al. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. , 2000, Circulation.
[68] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[69] L. Fulton,et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. , 2008, Cell host & microbe.
[70] T. Finkel,et al. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus , 1996, The Lancet.
[71] J E Parrillo,et al. Myocardial dysfunction in septic shock. , 2000, Critical care clinics.
[72] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[73] M. Färkkilä,et al. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. , 2011, Journal of Crohn's & colitis.
[74] R. Beale,et al. Assessment of Splanchnic Oxygenation by Gastric Tonometry in Patients with Acute Circulatory Failure , 1994 .
[75] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[76] O. Febo,et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. , 1995, Circulation.
[77] R. Knight,et al. The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice , 2009, Science Translational Medicine.
[78] Xianzhong Meng,et al. Toll-like receptor 4 mediates oxidized - LDL induced macrophage differentiation to foam cells , 2010 .
[79] Ruth E Ley,et al. Obesity and the human microbiome , 2010, Current opinion in gastroenterology.
[80] S. Anker,et al. The importance of the gastrointestinal system in the pathogenesis of heart failure. , 2005, European heart journal.
[81] S. Anker,et al. The emerging role of the gut in chronic heart failure , 2008, Current opinion in clinical nutrition and metabolic care.
[82] E. Gurfinkel,et al. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.
[83] K. Werdan,et al. Cardiodepression by tumor necrosis factor-alpha. , 1999, European cytokine network.
[84] N. Zhang,et al. Lipopolysaccharide induces endothelial cell apoptosis via activation of Na(+)/H(+) exchanger 1 and calpain-dependent degradation of Bcl-2. , 2012, Biochemical and biophysical research communications.
[85] A. Thompson. Developmental origins of obesity: Early feeding environments, infant growth, and the intestinal microbiome , 2012, American journal of human biology : the official journal of the Human Biology Council.
[86] B. Melichar,et al. Intestinal Permeability and Vitamin A Absorption in Patients With Chemotherapy-Induced Diarrhea , 2008, American journal of clinical oncology.
[87] Samantha A. Tavener,et al. Immune Cell Toll-Like Receptor 4 Is Required for Cardiac Myocyte Impairment During Endotoxemia , 2004, Circulation research.
[88] J. Mazière,et al. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells. , 1999, Atherosclerosis.
[89] G. Schuler,et al. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure , 2003, European journal of heart failure.
[90] J. Parrillo,et al. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide. , 2001, Journal of cardiothoracic and vascular anesthesia.
[91] P. Ferdinandy,et al. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. , 2003, Cardiovascular research.
[92] Julia Oh,et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis , 2012, Genome research.